The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Threshold mechanisms and site specificity in chromium(VI) carcinogenesis
Abstract
Ten years have elapsed since the International Agency for Research on Cancer (IARC) evaluated the carcinogenicity of chromium and chromium compounds. Further studies performed during the last decade have provided further epidemiological, experimental and mechanistic data which support the IARC conclusions. A wealth of results indicate that, at variance with chromium(0) and chromium(III), chromium(VI) can induce a variety of genetic and related effects in vitro. The lack of carcinogenicity of chromium(0) and chromium(III) compounds in experimental animals is well established, and only a minority of animal carcinogenicity data with chromium(VI) compounds were positive (30 out of 70, i.e. 42.9%). Moreover, most positive studies used administration routes which do not mimic any human exposure and by-pass physiological defense mechanisms. Typically, positive results were only obtained at implantation sites and at the highest dose tested. Exposure to chromium(VI) has been known for more than a century to be associated with induction of cancer in humans. Carcinogenicity requires massive exposures, as is only encountered in well defined occupational settings, and is site specific, being specifically targeted to the lung and, in some cases, to the sinonasal cavity. Increased death rates for cancers at other sites, which were occasionally reported in some epidemiological studies, were almost invariably not statistically significant, and inconsistent (being counterbalanced by other studies which apparently showed decreased rates for the same cancers). As we recently quantified in human body compartments, chromium(VI) can be reduced in body fluids and non-target cells, which results in its detoxification, due to the poor ability of chromium(III) to cross cell membranes. In target cells, chromium(VI) tends to be metabolized by a network of mechanisms leading to generation of reduced chromium species and reactive oxygen species, which will result either in activation or in detoxification depending on the site of the intracellular reduction and its proximity to DNA. When introduced by the oral route, chromium(VI) is efficiently detoxified upon reduction by saliva and gastric juice, and sequestration by intestinal bacteria. If some chromium(VI) is absorbed by the intestine, it is massively reduced in the blood of the portal system and then in the liver. These mechanisms explain the lack of genotoxicity, carcinogenicity, and induction of other long-term health effects of chromium (VI) by the oral route. Within the respiratory tract, chromium(VI) is reduced in the epithelial-lining fluid, pulmonary alveolar macrophages, bronchial tree and peripheral lung parenchyma cells. Hence, lung cancer can only be induced when chromium(VI) doses overwhelm these defense mechanisms. The efficient uptake and reduction of chromium(VI) in red blood cells explains its lack of carcinogenicity at a distance from the portal of entry into the body. All experimental and epidemiological data, and the underlying mechanisms, point to the occurrence of thresholds in chromium(VI) carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
The Journal of Laboratory and Clinical Medicine
(2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00127-6 · Cited by 1,767
Geigy, J. R. (1981) · Medical Entomology and Zoology · Cited by 1,221
Integrated risk information system (IRIS)
Tuxen, L. C. (1990) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 1,159
British Journal of industrial medicine
(1987) · Journal of Sound and Vibration · doi:10.1016/0022-460x(87)90429-9 · Cited by 1,049
Normal alveolar epithelial lining fluid contains high levels of glutathione
Cantin, A. M., North, S. L., Hubbard, R. C., & Crystal, R. G. (1987) · Journal of Applied Physiology · doi:10.1152/jappl.1987.63.1.152 · Cited by 797
British journal of industrial medicine
(1989) · Journal of Sound and Vibration · doi:10.1016/0022-460x(89)90628-7 · Cited by 751
THE TAGGING OF RED CELLS AND PLASMA PROTEINS WITH RADIOACTIVE CHROMIUM 1
Gray, S. J., & Sterling, K. (1950) · Journal of Clinical Investigation · doi:10.1172/jci102403 · Cited by 686
Toxicity and Carcinogenicity of Cr(VI) in Animal Models and Humans
Costa, M. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709078442 · Cited by 618
Mechanisms of Chromium Carcinogenicity and Toxicity
Cohen, M. D., Kargacin, B., Klein, C. B., & Costa, M. (1993) · Critical Reviews in Toxicology · doi:10.3109/10408449309105012 · Cited by 543
Cited by
Advances in metal-induced oxidative stress and human disease
Jomova, K., & Valko, M. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.001 · Cited by 3,207
Rahman, Z., & Singh, V. P. (2019) · Environmental Monitoring and Assessment · doi:10.1007/s10661-019-7528-7 · Cited by 1,473
Chromium in Drinking Water: Sources, Metabolism, and Cancer Risks
Zhitkovich, A. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200251t · Cited by 1,132
Heavy metals: toxicity and human health effects
Jomova, K., Alomar, S. Y., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03903-2 · Cited by 983
Salnikow, K., & Zhitkovich, A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700198a · Cited by 924
Toxicity and Carcinogenicity of Chromium Compounds in Humans
Costa, M., & Klein, C. B. (2006) · Critical Reviews in Toxicology · doi:10.1080/10408440500534032 · Cited by 904
Chromium Pollution in European Water, Sources, Health Risk, and Remediation Strategies: An Overview
Tumolo, M., Ancona, V., De Paola, D., Losacco, D., Campanale, C., Massarelli, C., & Uricchio, V. F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155438 · Cited by 590
Toxic and genotoxic effects of hexavalent chromium in environment and its bioremediation strategies
Mishra, S., & Bharagava, R. N. (2016) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590501.2015.1096883 · Cited by 513
Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms
O’Brien, T. J., Ceryak, S., & Patierno, S. R. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.09.006 · Cited by 509
Mechanisms of bacterial resistance to chromium compounds
Ramírez-Díaz, M. I., Díaz-Pérez, C., Vargas, E., Riveros-Rosas, H., Campos-García, J., & Cervantes, C. (2008) · BioMetals · doi:10.1007/s10534-007-9121-8 · Cited by 381
Chromium genotoxicity: A double-edged sword
Nickens, K. P., Patierno, S. R., & Ceryak, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.018 · Cited by 374
Oral Chromium Exposure and Toxicity
Sun, H., Brocato, J., & Costa, M. (2015) · Current Environmental Health Reports · doi:10.1007/s40572-015-0054-z · Cited by 368
Chromium Contamination and Its Risk Management in Complex Environmental Settings
Choppala, G., Bolan, N., & Park, J. H. (2013) · Advances in Agronomy · doi:10.1016/b978-0-12-407686-0.00002-6 · Cited by 314
Becker, R. A., Ankley, G. T., Edwards, S. W., Kennedy, S. W., Linkov, I., Meek, B., Sachana, M., Segner, H., Van Der Burg, B., Villeneuve, D. L., et al. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.04.004 · Cited by 266
Occupation and cancer in Britain
Rushton, L., Bagga, S., Bevan, R., Brown, T. P., Cherrie, J. W., Holmes, P., Fortunato, L., Slack, R., Van Tongeren, M., Young, C., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605637 · Cited by 265
Tannin-based biosorbents for environmental applications – A review
Bacelo, H. A. M., Santos, S. C. R., & Botelho, C. M. S. (2016) · Chemical Engineering Journal · doi:10.1016/j.cej.2016.06.044 · Cited by 261
S-Nitrosylation of Bcl-2 Inhibits Its Ubiquitin-Proteasomal Degradation
Azad, N., Vallyathan, V., Wang, L., Tantishaiyakul, V., Stehlik, C., Leonard, S. S., & Rojanasakul, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602551200 · Cited by 194
3D printed device for the automated preconcentration and determination of chromium (VI)
Calderilla, C., Maya, F., Cerdà, V., & Leal, L. O. (2018) · Talanta · doi:10.1016/j.talanta.2018.02.065 · Cited by 68
The solubility of Cr(III) and Cr(VI) compounds in soil and their availability to plants
MANDIWANA, K., PANICHEV, N., KATAEVA, M., & SIEBERT, S. (2007) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2007.01.049 · Cited by 39
Metadata
- Authors
- De Flora, S.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-04-01
- Volume
- 21
- Issue
- 4
- Pages
- 533-541
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2159969974
- Cited by
- 339
- References
- 43
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.